Evidence map›Paper›PMID 23920643›Full record

ArticleStudies in health technology and informatics2013

Using linked data for mining drug-drug interactions in electronic health records.

Jyotishman Pathak, Richard C Kiefer, Christopher G Chute

Abstract read
In one paragraph

Article in Studies in health technology and informatics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Biomedical literature-based clinical phenotype definition discovery using large language models.Database : the journal of biological databases and curation · 2025
    Article
  2. Article
  3. TP-DDI: A Two-Pathway Deep Neural Network for Drug-Drug Interaction Prediction.Interdisciplinary sciences, computational life sciences · 2022
    Article
  4. Article
  5. Review
  6. Review
  7. A computational approach to predict multi-pathway drug-drug interactions: A case study of irinotecan, a colon cancer medication.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2020
    Article
  8. Article
  9. An Informatics-based Approach to Identify Key Pharmacological Components in Drug-Drug Interactions.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2020
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Mining Electronic Health Records using Linked Data.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2015
    Article
  16. Rapid learning in practice: a lung cancer survival decision support system in routine patient care data.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2014
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jyotishman PathakDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Richard C Kiefer
Christopher G Chute

Funding

Genomic Basis of Susceptibility to COVID-19 Infection and its ComplicationsU01HG006379 · NHGRI · MAYO CLINIC ROCHESTER · PI Richard R. Sharp · 2011 to 2026
$16.5M
Pharmacogenetics of Phase II Drug Metabolizing EnzymesU19GM061388 · NIGMS · MAYO CLINIC ROCHESTER · PI WEINSHILBOUM, RICHARD M. · 2010 to 2014
$15.8M
National Infrastructure for Standardized and Portable EHR Phenotyping AlgorithmsR01GM105688 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI LUO, YUAN, PATHAK, JYOTISHMAN · 2013 to 2020
$5.7M
NHGRI NIH HHS U01 HG006379NHGRI NIH HHS U01-HG-006379NIGMS NIH HHS R01 GM105688NIGMS NIH HHS U19 GM061388NIGMS NIH HHS U19-GM-061388
6 · The paper itself

Abstract

By nature, healthcare data is highly complex and voluminous. While on one hand, it provides unprecedented opportunities to identify hidden and unknown relationships between patients and treatment outcomes, or drugs and allergic reactions for given individuals, representing and querying large network datasets poses significant technical challenges. In this research, we study the use of Semantic Web and Linked Data technologies for identifying drug-drug interaction (DDI) information from publicly available resources, and determining if such interactions were observed using real patient data. Specifically, we apply Linked Data principles and technologies for representing patient data from electronic health records (EHRs) at Mayo Clinic as Resource Description Framework (RDF), and identify potential drug-drug interactions (PDDIs) for widely prescribed cardiovascular and gastroenterology drugs. Our results from the proof-of-concept study demonstrate the potential of applying such a methodology to study patient health outcomes as well as enabling genome-guided drug therapies and treatment interventions.

Indexed as

Adverse Drug Reaction Reporting SystemsElectronic Health RecordsInternetNatural Language ProcessingArtificial IntelligenceData MiningDrug InteractionsDrug-Related Side Effects and Adverse ReactionsMedical Record LinkageSemantics

Identifiers

PMID23920643
PMCPMC3909652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.